Seeking Alpha
10 Jul 2026, 10:32 UTC · 2h ago
Medtronic: Guidance Built To Be Beaten - Buy
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Seeking Alpha
10 Jul 2026, 10:32 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Fiscal 2027 guidance excludes potential catalysts such as MiniMed separation, tariff refunds, and Blackstone payment relief. — Excluded positive catalysts create a high probability of upside surprises to earnings and revenue.
+0.60Medtronic achieved $36.4B in fiscal 2026 revenue, marking its strongest growth in a decade. — Strong historical growth momentum suggests operational recovery and increased competitiveness.
+0.40Cardiovascular and ablation solutions are currently outpacing overall market growth rates. — Market share gains in core segments indicate strong product demand and pricing power.
+0.30Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
The company has a 'buy' rating, a price target of $92, and recorded its strongest revenue growth in a decade.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
24/7 Wall Street
1h ago
